Modulatory effects of GLT-1 enhancer, MC-100093, on glutamate uptake and associated signaling pathways in female and male alcohol preferring rats exposed to ethanol.

IF 3.7 2区 医学 Q1 CLINICAL NEUROLOGY
Ahmed Alotaibi, Khokon Kanti Bhowmik, Woonyen Wong, Adil Shareef Mohammed, Magid Abou-Gharbia, Wayne Childers, Youssef Sari
{"title":"Modulatory effects of GLT-1 enhancer, MC-100093, on glutamate uptake and associated signaling pathways in female and male alcohol preferring rats exposed to ethanol.","authors":"Ahmed Alotaibi, Khokon Kanti Bhowmik, Woonyen Wong, Adil Shareef Mohammed, Magid Abou-Gharbia, Wayne Childers, Youssef Sari","doi":"10.1093/ijnp/pyaf075","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ethanol consumption disrupts glutamate homeostasis in several brain regions. The uptake of extracellular glutamate is regulated in the majority by the astrocytic glutamate transporter 1 (GLT-1), and cystine-glutamate exchanger (xCT) contributes to this regulatory effect. Chronic ethanol consumption is well known to downregulate GLT-1 expression in several reward brain regions, including the nucleus accumbens (NAc).</p><p><strong>Objectives: </strong>Recently, we reported that a novel beta-lactam, MC-100093, attenuated ethanol consumption and normalized the expression of GLT-1 in the subregions of the NAc. Based on these findings, we aimed in this study to determine the dose-dependent effect of MC-100093 in attenuating ethanol consumption and whether this attenuating effect is associated with restoration of glutamate homeostasis. Additionally, we focused on whether the effects of MC-100093 on GLT-1 are mediated through the mTOR, Akt, and NFkB signaling pathways.</p><p><strong>Methods: </strong>Male and female alcohol-preferring (P) rats are grouped into four groups. Other than control groups all the three groups had free access to ethanol (15% and 30% v/v), and water for five weeks. On Week 6, rats received i.p. MC-100093 at a dosage of 100 mg/kg or 150 mg/kg, or saline, for five days. The Na+ dependent and Na+ independent glutamate uptake is measured by radioactive glutamate uptake assay. The expressions of GLT-1, XCT, mTOR, Akt, IkBa and NFkB are determined by Western Blot analysis.</p><p><strong>Results: </strong>MC-100093 treatment resulted in reduced ethanol drinking in male and female P rats. MC-100093 was associated with an increase in Na+-dependent and Na+-independent glutamate uptake. Furthermore, MC-100093 treatment attenuated ethanol-induced decrease in GLT-1, xCT, NFkB, and p-Akt expression in the NAc.</p><p><strong>Conclusions: </strong>These findings demonstrate that MC-100093 attenuated ethanol consumption and regulated glutamate uptake through normalizing GLT-1 expression.</p>","PeriodicalId":14134,"journal":{"name":"International Journal of Neuropsychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Neuropsychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ijnp/pyaf075","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Ethanol consumption disrupts glutamate homeostasis in several brain regions. The uptake of extracellular glutamate is regulated in the majority by the astrocytic glutamate transporter 1 (GLT-1), and cystine-glutamate exchanger (xCT) contributes to this regulatory effect. Chronic ethanol consumption is well known to downregulate GLT-1 expression in several reward brain regions, including the nucleus accumbens (NAc).

Objectives: Recently, we reported that a novel beta-lactam, MC-100093, attenuated ethanol consumption and normalized the expression of GLT-1 in the subregions of the NAc. Based on these findings, we aimed in this study to determine the dose-dependent effect of MC-100093 in attenuating ethanol consumption and whether this attenuating effect is associated with restoration of glutamate homeostasis. Additionally, we focused on whether the effects of MC-100093 on GLT-1 are mediated through the mTOR, Akt, and NFkB signaling pathways.

Methods: Male and female alcohol-preferring (P) rats are grouped into four groups. Other than control groups all the three groups had free access to ethanol (15% and 30% v/v), and water for five weeks. On Week 6, rats received i.p. MC-100093 at a dosage of 100 mg/kg or 150 mg/kg, or saline, for five days. The Na+ dependent and Na+ independent glutamate uptake is measured by radioactive glutamate uptake assay. The expressions of GLT-1, XCT, mTOR, Akt, IkBa and NFkB are determined by Western Blot analysis.

Results: MC-100093 treatment resulted in reduced ethanol drinking in male and female P rats. MC-100093 was associated with an increase in Na+-dependent and Na+-independent glutamate uptake. Furthermore, MC-100093 treatment attenuated ethanol-induced decrease in GLT-1, xCT, NFkB, and p-Akt expression in the NAc.

Conclusions: These findings demonstrate that MC-100093 attenuated ethanol consumption and regulated glutamate uptake through normalizing GLT-1 expression.

GLT-1增强子MC-100093对暴露于乙醇的雌性和雄性酒精偏好大鼠谷氨酸摄取和相关信号通路的调节作用
背景:乙醇消耗会破坏大脑几个区域的谷氨酸稳态。细胞外谷氨酸的摄取主要由星形细胞谷氨酸转运蛋白1 (GLT-1)调节,而胱氨酸-谷氨酸交换剂(xCT)参与了这种调节作用。众所周知,慢性乙醇消耗会下调包括伏隔核(NAc)在内的几个脑奖赏区GLT-1的表达。目的:最近,我们报道了一种新的β -内酰胺MC-100093,可以减少乙醇消耗,并使NAc亚区GLT-1的表达正常化。基于这些发现,我们在本研究中旨在确定MC-100093在减少乙醇消耗方面的剂量依赖效应,以及这种减弱效应是否与谷氨酸稳态的恢复有关。此外,我们关注MC-100093对GLT-1的影响是否通过mTOR、Akt和NFkB信号通路介导。方法:将雌雄嗜酒大鼠分为四组。与对照组不同的是,三组小鼠在五周的时间里都可以自由使用乙醇(15%和30% v/v)和水。在第6周,大鼠接受剂量为100mg /kg或150mg /kg的i.p. MC-100093,或生理盐水,持续5天。用放射性谷氨酸摄取法测定Na+依赖性和Na+非依赖性谷氨酸摄取。Western Blot检测GLT-1、XCT、mTOR、Akt、IkBa、NFkB的表达。结果:MC-100093处理导致雄性和雌性P大鼠的乙醇饮用减少。MC-100093与Na+依赖性和Na+非依赖性谷氨酸摄取增加有关。此外,MC-100093处理减弱了乙醇诱导的NAc中GLT-1、xCT、NFkB和p-Akt表达的降低。结论:这些发现表明MC-100093通过使GLT-1表达正常化来减弱乙醇消耗和调节谷氨酸摄取。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.40
自引率
2.10%
发文量
230
审稿时长
4-8 weeks
期刊介绍: The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology and neuropsychology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信